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ABSTRACT
Cytoplasmic polyadenylation is important in the control of mRNA stability and translation, and for early animal development
and synaptic plasticity. Here, we focus on vertebrate poly(A) polymerases that are members of the recently described GLD2
family. We identify and characterize two closely related GLD2 proteins in Xenopus oocytes, and show that they possess PAP
activity in vivo and in vitro and that they bind known polyadenylation factors and mRNAs known to receive poly(A) during
development. We propose that at least two distinct polyadenylation complexes exist in Xenopus oocytes, one of which contains
GLD2; the other, maskin and Pumilio. GLD2 protein interacts with the polyadenylation factor, CPEB, in a conserved manner.
mRNAs that encode GLD2 in mammals are expressed in many tissues. In the brain, mouse, and human GLD2 mRNAs
are abundant in anatomical regions necessary for long-term cognitive and emotional learning. In the hippocampus, mouse
GLD2 mRNA colocalizes with CPEB1 and Pumilio1 mRNAs, both of which are likely involved in synaptic plasticity. We
suggest that mammalian GLD2 poly(A) polymerases are important in synaptic translation, and in polyadenylation throughout
the soma.
Keywords: poly(A) polymerase; GLD2; translational control

INTRODUCTION
Control of the movement, translation and stability of
mRNAs determines when, where, and how much protein
an mRNA generates (for reviews, see Sonenberg 1994;
Hentze 1995; Wickens et al. 2002; Kuersten and Goodwin
2003). A tract of adenosines at the 30 end of the mRNA—
the poly(A) tail—plays a key role in these events. Cytoplasmic lengthening of the tail can activate translation and
stabilize the mRNA, while poly(A) removal can cause
translational repression and mRNA decay. Regulated
changes in the length of the poly(A) tail are critical during
early development; for example, they control the meiotic
and mitotic cell cycles of Xenopus oocytes and embryos by
regulating specific mRNAs (for reviews, see Mendez and
Richter 2001; Wickens et al. 2002). In the nervous system,
repeated stimulation of synapses activates polyadenylation

Reprint requests to: Marvin Wickens, Department of Biochemistry,
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biochem.wisc.edu; fax (608) 262-9108.
Article and publication are at http://www.rnajournal.org/cgi/doi/
10.1261/rna.2630205.

and local translation (Wu et al. 1998; Huang et al. 2002; Si
et al. 2003a; Theis et al. 2003). These polyadenylation
events are thought to be important in long-term potentiation (LTP) and learning (Wu et al. 1998; Alarcon et al.
2004).
Cytoplasmic polyadenylation in frog oocytes requires
multiple protein components, including Cytoplasmic Polyadenylation Element Binding Protein (CPEB) and Cleavage
and Polyadenylation Specificity Factor (CPSF) (for reviews,
see Mendez and Richter 2001). CPEB binds directly to
specific sequences in the 30 UTRs of target mRNAs (Hake
et al. 1998). CPSF, a multiprotein complex, binds the
sequence AAUAAA and is necessary for both nuclear and
cytoplasmic polyadenylation (Bilger et al. 1994). CPEB
binds CPSF, which is thought then to recruit the enzyme
that adds the poly(A), a cytoplasmic poly(A) polymerase
(PAP) (Mendez et al. 2000; Dickson et al. 2001). Although
oocytes contain cytoplasmic PAPs related to the nuclear
enzyme (Ballantyne et al. 1995; Gebauer and Richter 1995),
their role in cytoplasmic polyadenylation is unclear.
GLD-2, a divergent cytoplasmic PAP, was identified in
Caenorhabditis elegans (Wang et al. 2002), and is related to
the Cid1 and Cid13 PAPs of Schizosaccharomyces pombe
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(Read et al. 2002; Saitoh et al. 2002). GLD-2 polymerization activity is stimulated by interaction with an RNA
binding protein, GLD-3 (Wang et al. 2002). Together
GLD-2 and GLD-3 are thought to form a novel heterodimeric PAP, in which the RNA binding component, GLD3, recruits the catalytic subunit, GLD-2, to specific mRNAs
(Wang et al. 2002; Kwak et al. 2004). Homologs of GLD-2
that possess polyadenylation activity recently were identified in mice and humans (Kwak et al. 2004). Similarly, a
Xenopus protein related to GLD-2 was identified by virtue
of its association with CPEB and shown to participate in
cytoplasmic polyadenylation in oocytes (Barnard et al.
2004).
Repression of specific mRNAs in oocytes and embryos
involves multiple RNA binding proteins. In Xenopus
oocytes, maskin, Pumilio, and Nanos (Xcat-2) all appear
to be bound to repressed RNAs and involved in repression
(Stebbins-Boaz et al. 1999; Nakahata et al. 2001, 2003; for
review, see Richter 2000). Maskin binds CPEB on the
30 UTR, and sequesters eIF4E to repress translation
(Stebbins-Boaz et al. 1999; for review, see Richter 2000).
Similarly, Nanos and PUF (e.g., Pumilio) proteins interact
physically and assemble on specific sequences in the 30 UTR
(Kraemer et al. 1999; Sonoda and Wharton 1999; Nakahata
et al. 2001; for review, see Wickens et al. 2002). These
multiprotein complexes are required for repression. Release
from repression is accompanied by cytoplasmic polyadenylation.
Translational regulation of dendritic mRNAs is important in synaptic plasticity. Stimulation of synapses results in
locally increased protein synthesis, which requires cytoplasmic polyadenylation and CPEB (Si et al. 2003a). This local
translation is required for the late phase of LTP, an electrophysiological, cellular correlate of memory (Nguyen et al.
1994; Frey et al. 1988; Liu and Schwartz 2003; for reviews,
see Wells et al. 2000; Richter 2001; Tang and Schuman
2002). Four isoforms of CPEB are found in the hippocampus (Wu et al. 1998; Theis et al. 2003). Knockout mice
lacking one of these, mCPEB1, exhibit a modest deficit in
LTP (Alarcon et al. 2004). After LTP induction, cytoplasmic polyadenylation regulates the translation of proteins
enriched in synaptic spines, including aCaMKII (Wu et al.
1998; Miller et al. 2002; Otmakhov et al. 2004), cytoskeletal
actin (Fukazawa et al. 2003; Liu and Schwartz 2003;
Matsuzaki et al. 2004), Erg1 (Simon et al. 2004), and tissue
plasminogen activator (TPA) (Shin et al. 2004). Both Erg1
and TPA are necessary for LTP and long-term memory
formation (Jones et al. 2001; Pawlak et al. 2002; Malkani
et al. 2004; Pang et al. 2004).
In this paper, we focus on GLD2 in vertebrates. We
identify two Xenopus GLD-2 enzymes and analyze their
interaction with known polyadenylation factors, confirming and extending the work of Barnard et al. (2004). We
demonstrate that the mammalian enzymes associate with
Xenopus polyadenylation factors, and that they are
1118
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expressed in regions of the hippocampus associated with
learning and memory. Their expression pattern in the
hippocampus parallels that of CPEB1 and Pumilio1, both
of which are implicated in synaptic plasticity. Based on
these findings. we suggest the existence of two distinct
translational control complexes in oocytes, and propose
that the GLD2 PAP participates in translational activation
at synapses.
RESULTS
Vertebrate GLD2 homologs: proteins and mRNAs
We recently identified C. elegans, murine, and human
homologs of C. elegans GLD-2 (Wang et al. 2002; Kwak
et al. 2004). To identify the enzyme that catalyzes cytoplasmic polyadenylation in frog oocytes, we designed degenerate primers directed against regions conserved among
GLD2 homologs, and performed PCR to identify GLD2related cDNAs in a Xenopus oocyte cDNA library. We
determined the sequences of two independent isolates of
Xenopus GLD-2 cDNA that comprised the entire ORF, and
six cDNAs from the NIBB (Japan) and the IMAGE consortium. These sequences were consolidated with those of
40 fragmentary ESTs (see Materials and Methods).
Two different isoforms of Xenopus leaevis GLD-2,
termed XlGLD-2A and XlGLD-2B, were identified. The
two predicted proteins are 88% identical and differ in
nucleotide sequence at multiple locations throughout
their length. All cDNAs and ESTs belonged to one group
or the other, suggesting that XlGLD-2A and XlGLD-2B are
different genes. XlGLD-2B corresponds to the protein
recently shown to be involved in cytoplasmic polyadenylation (Barnard et al. 2004). XlGLD-2A and XlGLD-2B each
are 62% identical to human and mouse GLD-2 (hGLD2
and mGLD2) (Kwak et al. 2004) and 42% identical to
catalytic and central domains of the C. elegans protein.
The predicted Xenopus proteins possess the hallmarks of
the b-nucleotidyl transferase superfamily, including specific amino acids that participate in catalysis and bind the
nucleotide (Fig. 1A, red and green residues; Aravind and
Koonin 1998; Martin et al. 2004).
We analyzed by Northern blotting the mRNA produced
from the XlGLD-2 genes, and compared it to the mouse
and human GLD2 mRNAs. In all three species, two
mRNA forms were detected, which we term GLD2(L)
and GLD2(S) (Fig. 1B,C). Each apparent 30 end was
deduced from the location of poly(A) on multiple
cDNAs and ESTs, and was preceded by a polyadenylation
signal (Fig. 1B). The two mRNAs produced from one
gene in each species are identical in the protein coding
region but differ in the length of their 30 UTRs. This was
deduced from multiple cDNAs and corroborated by using
a probe that was predicted to detect only mGLD2(L) form
(Fig 1D). In Xenopus, XlGLD-2A produces two forms;
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XlGLD-2B expresses one mRNA with a long 30 UTR (data
not shown). Human cDNAs representing alternatively
spliced variants that lack exon 8 or exon 11 were detected
among ESTs (D8 and D11; indicated in Fig. 1A).
Throughout the protein coding region, each of the vertebrate genes display identical exon-intron organizations
(data not shown).
We next focused on the activity and biological role of
GLD2 protein in Xenopus oocytes. Antibodies raised
against XlGLD-2A were used to examine the abundance
and subcellular distribution of endogenous XlGLD-2 protein. The antibodies were specific: In vitro translation of an
mRNA encoding HA-tagged GLD-2A yielded a single protein of 60 kDa that was detected by a-XlGLD-2 and
a-HA antibodies (Fig. 2A, lanes 2,5). This protein comigrates with the endogenous oocyte protein (Fig. 2, lanes
2,3). The antibody recognizes both XlGLD-2A and
XlGLD-2B proteins (data not shown). A single prominent
polypeptide was detected throughout oogenesis, oocyte
maturation, and post-fertilization development (Fig. 2B;
data not shown).
The factors needed to catalyze regulated polyadenylation
during oocyte maturation are cytoplasmic (Fox et al. 1989).
XlGLD-2 protein was detected in the oocyte cytoplasm, as
well as the nucleus (Fig. 2C). a-XlPABP2 antibodies confirmed that the manual separation of nuclei and cytoplasms
was successful, since nPABP2 was predominantly nuclear
(Good et al. 2004).

XLGLD-2 is a PAP

FIGURE 1. XlGLD-2, mGLD2, and hGLD2 mRNAs and proteins.
(A) Predicted protein sequences in the catalytic and central domains
of GLD2 homologs. The sequences from five animal different species
(X. laevis, X. tropicalis, mouse, human, and C. elegans) are presented. Black
indicates amino acid identity; red, three carboxylate side-chains required
for catalysis; green, six residues that position the nucleotide (Martin
et al. 2000; Wang et al. 2002); and red asterisk, location of the active site
mutation, D242A. Colored bars above the sequence indicate the central
(purple) or catalytic (yellow) domains. Black lines below the sequence
indicate the regions missing in D8 and D11 forms of the human protein.
(B) Vertebrate GLD2 mRNAs. Approximate lengths of mRNAs, as
calculated by cDNA sequencing and confirmed by Northern blotting, are
shown to the left of each panel. Purple indicates PAP central domain;
yellow, PAP catalytic domail (corresponding to Fig 1A). Percentage of
amino acid sequence identity relative to XlGLD-2A is given (percentage
similarity is in parentheses). Black circles and boxes indicate 50 cap and
30 cleavage and polyadenylation signal (AAUAAA and AAUACA). Distances from the termination codon to the poly(A) tail are indicated.
(C) Two mRNA forms. RNAs from Xenopus oocytes, mouse 3T3 cells,
and human spleen were analyzed by Northern blotting. T indicates total
RNA; A+, RNA retained by oligo(dT) cellulose; and A-, RNA not retained
by oligo (dT). Amounts of RNA and hybidization probes are described in
Materials and Methods. (D) mGLD2(L) and mGLD2(S) mRNAs differ by
their 30 UTRs. Total RNA from spleen was analyzed by using either a probe
complementary to the entire ORF (left) or just the 30 UTR of the long form
of mRNA, mGLD2(L) (right).

To test whether the Xenopus GLD2 proteins possessed
PAP activity, we tethered XlGLD-2A to an mRNA reporter using MS2 coat protein. Oocytes first were injected
with mRNAs that direct the synthesis of MS2-XlGLD-2A
fusion proteins. After allowing time for protein to accumulate, the same oocytes were injected with luciferase
reporter mRNAs containing MS2 sites. A b-galactosidase
reporter mRNA lacking MS2 sites was coinjected as a
control. MS2-XlGLD-2A and MS2-XlGLD-2B proteins
stimulated translation of mRNAs containing MS2 sites
but did not affect translation of mRNAs lacking them
(Fig. 3A–C). A putative active site mutation, D242A,
abolished translational stimulation but accumulated to
the same level as did the wild-type protein (Fig. 3B). To
analyze polyadenylation directly, we injected 32P-labeled
RNAs bearing MS2 sites. The labeled RNA was polyadenylated in oocytes containing wild-type MS2-XlGLD-2A,
but not the D242A, form of fusion protein (Fig. 3D).
Furthermore, we purified recombinant, full-length human
GLD2 and XlGLD-2A proteins from bacteria. These
enzymes added long tails to 32P-labeled RNAs in vitro,
while a D242A mutant form of XlGLD-2A protein did
not (Fig. 3E). The added tails were composed of polywww.rnajournal.org
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FIGURE 2. XlGLD-2 is present throughout embryogenesis and is in
the cytoplasm. (A) Antibody specificity. mRNA encoding HA-XlGLD2A was translated in vitro, and the products were analyzed by Western
blotting using a-XlGLD-2 antibodies. A predominant protein of
60 kDa is detected by a-XlGLD-2 (lanes 1–3) and a-HA antibodies
(lanes 4–6). The in vitro translated protein (lane 2) roughly comigrates with endogenous XlGLD-2 protein in oocyte extracts (lane 3).
(B) XlGLD-2 protein abundance. Proteins extracted from the
indicated stages were analyzed by Western blotting using either
a-XlGLD-2 or a-actin. (C) XlGLD-2 subcellular distribution. Nuclear
and cytoplasmic fractions prepared manually from stage VI oocytes
were analyzed by Western blotting with a-XlGLD-2 (lanes 1–4).
a-XlPABP-2 (lanes 5–8), which detects a nuclear poly(A) binding
protein (Good et al. 2004), was used to control for proper enucleation
and a lack of leakage into the cytoplasm. N and C indicate nucleus
and cytoplasm, respectively.

adenosine, as they were removed by oligo(dT)/RNAse
treatment (data not shown).
We conclude that the two Xenopus proteins, XlGLD-2A
and XlGLD-2B, as well as human GLD2, possess PAP
activity. In the following experiments, we focus first on
the interaction of XlGLD-2A with proteins involved in
cytoplasmic polyadenylation and translational control,
and then turn to mouse and human GLD2.

XlGLD-2A interacts with polyadenylation
factors and target mRNAs
To test whether XlGLD-2 interacted with CPEB or CPSF,
recombinant GST-XlGLD-2A was attached to Sepharoseglutathione beads and incubated with crude lysates of stage
1120
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VI oocytes. The beads were washed with buffer, and bound
proteins were eluted and analyzed by Western blotting
(Fig. 4A). CPEB bound to GST-XlGLD-2A but not to either
GST-PUF-8 or GST alone, used as controls (Fig. 4A). A subunit
of CPSF, CPSF73, also bound specifically to GST-XlGLD-2A.
Maskin and Pumilio proteins, both of which are
involved in translational repression, physically interact
with CPEB in resting oocytes (Stebbins-Boaz et al. 1999;
Nakahata et al. 2003). In contrast, GST-XlGLD-2A binds
CPEB, but it did not bind either maskin or Pumilio proteins (Fig. 4A).
To test whether endogenous XlGLD-2 interacts with
CPSF, we performed coimmunoprecipitation experiments
(Fig. 4B). a-XlGLD-2 antibodies were incubated with
crude oocyte lysates, and the bound proteins were analyzed
by Western blotting. Oocytes first were injected with
mRNA encoding HA-XlGLD-2A. As expected, HA-tagged
XlGLD-2A was efficiently immunoprecipitated by the
a-XlGLD-2 antibodies (Fig 4B, ‘‘a-HA’’). Endogenous
CPSF100 and CPSF73 were immunoprecipitated by
a-XlGLD-2; maskin and Pumilio were not (Fig. 4B).
In a reciprocal experiment, we used a-CPEB antibodies
to immunoprecipitate complexes from oocyte lysates
(Fig. 4C). a-CPEB antibodies efficiently precipitated
HA-XlGLD-2A from the extracts, confirming that CPEB and
XlGLD-2 interact (Fig. 4C). The coimmunoprecipitation
of the two proteins was resistant to digestion with RNaseA that was sufficient to degrade the endogenous RNA
(Fig. 4D; data not shown). Thus the coimmunoprecipitation of CPEB and XlGLD-2 was not due to co-occupancy
of a single RNA. a-CPEB also immunoprecipitated CPSF
and maskin, as reported previously (Fig. 4C; Dickson
et al. 1999; Stebbins-Boaz et al. 1999; data not shown).
Together, the interaction data demonstrate that XlGLD-2
binds CPSF and CPEB, consistent with the results of
Barnard et al. (2004). We conclude that XlGLD-2 interacts with CPEB and CPSF, but does not interact with
maskin or Pumilio.
To test whether these interactions between GLD-2 and
Xenopus polyadenylation components were conserved, we
expressed wild-type human GLD2, and the D8 and D11
forms of human GLD2, in oocytes. The wild-type and D8
forms of hGLD2 were immunoprecipitated by a-CPEB; the
D11 form was not (Fig. 4E). Similarly, the D8 form was
active in polyadenylation assays, while D11 was inactive
(data not shown).
If XlGLD-2 catalyzes cytoplasmic polyadenylation, then
it must associate with mRNAs that receive poly(A). We
asked whether cyclin B1 mRNA, an mRNA that is polyadenylated during oocyte maturation, was bound to
XlGLD-2 in stage VI oocyte (Fig. 5). Oocyte lysates were
incubated with a-XlGLD-2 antibodies, and the immunoprecipitated RNAs were extracted and analyzed by RT-PCR
(Fig. 5). Cyclin B1 mRNA was readily detected in immunoprecipitates obtained with a-XlGLD-2, but not with
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control, preimmune antibodies (Fig. 5). Actin and ribosomal protein L1 mRNAs were not specifically immunoprecipitated by a-GLD2, as they were present at equivalent,
low levels in the a-XlGLD-2 and preimmune immunoprecipitates (Fig. 5). c-mos mRNA, which also receives poly(A)
during maturation, was associated with XlGLD-2 as well
(data not shown).
Taken together, our findings imply that at least two
complexes exist in resting, stage VI oocytes (Fig. 4F).
One, which we term the G complex (for GLD-2), contains
GLD-2 and CPEB. The other complex, which we term MP
(for maskin and Pumilio), contains CPEB, maskin, and
Pumilio. CPSF is present in one or both complexes. The
finding that XlGLD-2 associates with symplekin, and is
stimulated by that protein in combination with CPSF,
implies that symplekin and CPSF are in the G complex
(Barnard et al. 2004).
Expression of mammalian GLD2 homologs

FIGURE 3. Vertebrate GLD2 homologs are poly(A) polymerases in
vivo and in vitro. (A) Translational stimulation in vivo. Oocytes
containing MS2/XlGLD-2A protein increase the expression of a
luciferase reporter mRNA that contains MS2 binding sites in its
30 UTR (left), but does not increase expression with an mRNA
reporter that lacks MS2 binding sites (right). Luciferase activity is
normalized to that of b-galactosidase, generated from a coinjected
mRNA that lacks MS2 binding sites. (B) An active site mutation
abolishes translational stimulation. Oocytes containing MS2XlGLD-2A protein with an active site mutation, D242A, do not
stimulate translation of the luciferase reporter mRNA that contains
MS2 sites. The wild-type protein was used as a control. Western
blotting with a-HA antibodies demonstrates the wild-type and
mutant proteins are comparable in abundance. (C) XlGLD-2B is
active in vivo. Oocytes containing MS2-XlGLD-2B protein increase
the expression of a luciferase reporter mRNA that contains MS2
binding sites in its 30 UTR (left). The point mutant protein was
used as a control and is inactive. Western blotting with a~HA
antibodies demonstrated the wild-type and mutant proteins are
comparable in abundance (shown below the histogram). (D) Polyadenylation in vivo. A 32P-labeled RNA containing three MS2 sites
was injected into oocytes expressing either MS2-XlGLD-2 or
MS2-XlGLD-2A (D242A). Oocytes were collected after 16 h, and the
RNA was extracted and fractionated using biotinylated oligo(dT).
+ indicates RNAs that bound the resin; , RNAs that did not bind
the resin. Positions of RNAs carrying various lengths of poly(A)
(determined by using markers) are shown to the left. (E) Polyadenylation in vitro. Recombinant GST-XlGLD-2A, GST-XlGLD2A(D242A), and GST-hGLD2 proteins, purified from Escherichia
coli, were incubated at 24 C with L1 RNA (see Materials and
Methods) and a mixture of all four ribonucleoside triphosphates
at 1 mM. Samples were collected at the indicated time points and
analyzed by denaturing gel electrophoresis. Positions of RNAs
carrying various lengths of poly(A) (determined by using markers)
are shown to the left.

Our findings that mouse and human GLD2 are PAPs and
that they interact with polyadenylation factors in the Xenopus oocyte cytoplasm, suggested that the mammalian proteins were involved in regulated polyadenylation. We
examined the tissue distribution of GLD2 mRNAs in
mouse and human tissues by Northern blotting (Fig. 6).
GLD2 mRNAs are expressed in a wide range of tissues,
including the ovary, brain, and testes. Both mGLD2(S)
and mGLD2(L) were detected in each tissue. Their relative
abundance varied: for example, in the mouse brain,
mGLD2(L) mRNA was much more abundant than
mGLD2(S), while the opposite is true in placenta.
GLD2(L) mRNAs also were detected in RNA from human
brain and in RNAs prepared from isolated human cerebellum, hippocampus, and medulla (Fig. 6B). Again, the
GLD2(L) form predominated (Fig. 6B). Subcellular fractionation studies suggested that mGLD2 mRNA was enriched
in synaptic fractions (data not shown).
To determine more precisely the distribution of
mGLD2 mRNA within mouse brain, we performed in
situ hybridization on sagittal sections by using 35S-labeled
RNA probes (Fig. 7A). An antisense probe that detects
both mGLD2 mRNA isoforms yielded signal throughout
the brain in a pattern consistent with the presence of
mGLD2 transcripts within neurons. The distribution of
mGLD2(L) mRNA, detected by using an L-form–specific
probe, was identical (Fig. 7, cf. A and B). As expected, a
sense-strand probe yielded no significant signal (Fig. 7C).
The abundance of mGLD2 mRNA was highest in the
cerebral cortex, cerebellum, hippocampus, and olfactory
bulb. mGLD2 mRNA abundance paralleled neuronal density. In the hippocampus and cerebellum, for example,
intense mGLD2 mRNA expression was evident in the celldense, granule cell layers of the dentate gyrus and cerebellar cortex. We analyzed several other mRNAs in
www.rnajournal.org
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used as a control, differs substantially,
and is abundant in many regions of
the brain (Fig. 7G).
Since the hippocampus mediates certain types of long-term memory formation (Scoville and Milner 1957; for
review, see Eichenbaum 2004), we
examined the distribution of GLD2
transcripts in the hippocampus at
higher resolution. After hybridization,
sections were treated with radiographic
emulsion and visualized by darkfield
microscopy (Fig. 8). mGLD2 mRNA
was specifically detected in the granule
cell layer of the dentate gyrus (GCL)
and the pyramidal cell layer of the hippocampus (CA1, CA2, and CA3) (Fig.
8A). The distribution of mGLD2 mRNA
in the hippocampus was nearly identical to that of mCPEB1 and Pumilio1
mRNAs, which were analyzed in parallel sections (Fig. 8B,C). The distribution
of mRNA for the activity-regulated protein, ARC, was also similar to mGLD2
FIGURE 4. XlGLD-2 interacts with polyadenylation factors. (A) Proteins bound to GST- except that fewer cells in the granule
XlGLD-2A. Stage VI oocyte lysate was inubated with purified GST-XlGLD-2A, GST-PUF-8, or
cell layer expressed ARC mRNA, comGST, bound to glutathione-Sepharose. Proteins retained on beads after three washes were
analyzed by Western blotting with antibodies specific to CPEB, CPSF-73, maskin, and XlPu- pared with mGLD2 and Pumilio1
milio. Total indicates unfractionated lysate (fourfold less starting material than in the other mRNAs (Fig. 8D). In contrast, the dislanes). (B) Proteins coimmunoprecipitated with a-XlGLD-2. Crude lysates were prepared tribution of mRNA for the RNA bindfrom oocytes that were expressing HA/XlGLD-2. Lysates were incubated with a-XlGLD-2
(top panel) or a-CPEB (bottom panel), or with respective preimmune sera, as indicated ing protein, Quaking (Ebersole et al.
above each lane. Proteins were detected by Western blot analysis using a-CPSF100, a- 1996), differed dramatically from the
CPSF73, a-maskin, and a-XlPumilio, as indicated. Western analysis using a-HA as probe other mRNAs analyzed (Fig. 8E).
demonstrated that the a-XlGLD-2 antibody efficiently immunoprecipitates the endogenous Induction of seizures using pentyleneteprotein. Bound indicates proteins that bound to the beads; unbound, proteins that did not
bind to the beads. Total indicates unfractionated lysate (threefold less starting material than in trazole (PTZ) did not affect either the
bound, and equal starting material to unbound). (C) Proteins coimmunoprecipitated with a- abundance or distribution of mGLD2
CPEB. Oocytes were injected with mRNAs that encode HA-XlGLD-2. Oocyte lysates were mRNA, but dramatically increased the
incubated with a-CPEB, or with preimmune serum. Both XlGLD-2 and maskin are associated abundance of ARC mRNA, as expected
with a-CPEB. Total indicates unfractionated lysate (threefold less starting material than in
bound, and equal starting material to unbound). (D) Ribonuclease-resistance of the CPEB/ (Fig. 8F,G; Steward and Worley 2001).
We next focused on the cerebellum,
GLD-2 interaction. Xenopus oocyte extracts, prepared as in B, were treated with RNAseA. Gel
electrophoresis demonstrated that the RNA had been degraded (data not shown). Coimmu- where mGLD2 mRNA also is abundant
noprecipitations were performed with a-CPEB or preimmune sera, on X. laevis oocyte extracts
(Fig. 7). mGLD2 mRNA was present at
as in B. The two proteins continue to coimmunoprecipitate after RNAse treatment. (E)
Human GLD2/CPEB complexes. Immunoprecipitations using either a-CPEB or preimmune the highest levels in the granule (GCL)
antibodies were incubated with X. laevis oocyte extracts prepared from oocytes expressing and Purkinje (PCL) cell layers of cereeither HA-hGLD2, HA-hGLD2D8, or HA-hGLD2D11. Total indicates crude lysate. (F) Model bellar cortex (Fig. 7A). mGLD2 mRNA
of polyadenylation complexes in resting oocytes. See text for details. CPSF and CPEB are
was also present at a lower level, and in
shown interacting in the resting oocyte (Mendez et al. 2000; Dickson et al. 2001). However,
CPEB phosphorylation increases binding affinity to CPSF (Mendez et al. 2000). Symplekin is a diffuse distribution, throughout the
likely to be in the G complex, as inferred from the data of Barnard et al. (2004).
molecular cell layer (MCL) (Fig. 9A).
mCPEB1 mRNA, in contrast, was
expressed almost exclusively within the
large Purkinje neurons in the cerebelparallel sections. The distribution of mGLD2 mRNA was
lum (Fig. 9B). Interestingly, the pattern of mGLD2 expresalmost identical to the distribution of mouse Pumilio1
sion in the cerebellum was more similar to mCPEB2, 3, and
mRNA and was very similar to mCPEB1 in the hippo4, all of which were present in the major cerebellar neurocampus and to mCPEB4 in the cerebellum and olfactory
nal layers (Fig. 9C–E). These data imply regional specificity
bulb (Fig. 7D–F). The distribution of Quaking mRNA,
of cytoplasmic polyadenylation mechanisms in the brain.
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FIGURE 5. XlGLD-2 interacts with target, but not nontarget,
mRNAs. Oocyte extracts were incubated with a-XlGLD-2 or preimmune guinea pig serum and bound to Protein A–Sepharose. Bound
material was eluted and the RNA recovered. mRNAs were detected by
semiquantitative PCR, using oligo(dT)-primed reverse transcription
reactions, followed by PCR using gene-specific primers. Cyclin B1
mRNA receives poly(A) during oocyte maturation, and is immunoprecipitated by a-XlGLD-2. Cytoskeletal actin and ribosomal protein
L1 mRNAs do not receive poly(A) during maturation and are not
immunoprecipitated.

XlGLD-2 interacts with CPEB and CPSF but does not
interact with maskin or Pumilio. Maskin, Pumilio, and
CPEB are associated with repressed mRNAs in the oocyte
(for review, see Mendez and Richter 2001; Nakahata et al.
2001). Our findings imply that at least two complexes exist
in resting, stage VI oocytes (Fig. 4F). One contains GLD2,
CPEB, and CPSF. We term this the G complex (for GLD2).
The other complex contains CPEB, maskin, and Pumilio,
and so is termed MP (for maskin and Pumilio). The finding that XlGLD-2 associates with symplekin implies that it
too is in the G complex, which may contain other polyadenylation factors as well (Barnard et al. 2004).
Cyclin B1 mRNA is associated with GLD-2, and thus the
G complex (the current study). It also may be present in
the MP complex, since the cyclin B1 30 UTR can bind
Pumilio in extracts of stage VI oocytes (Nakahata et al.
2001). Although cyclin B1 mRNA is polyadenylated and
activated during oocyte maturation (Sheets et al. 1994),
some cyclin B1 mRNA molecules must already be active in
oocytes since oocytes contain cyclin B1 protein (Kobayashi
et al. 1991). Active and inactive mRNA molecules may be
partitioned differently between G and MP complexes. For
example, the G complex may contain actively translated
mRNAs. Alternatively, the mRNAs in G and MP
complexes may be regulated differently during maturation.

DISCUSSION
We have focused in this paper on three vertebrate GLD2
proteins. The Xenopus enzyme, which exists in two closely
related forms, polyadenylates RNAs to which it is tethered
and enhances their translation. Furthermore, it interacts
with cytoplasmic polyadenylation factors, including CPSF
and CPEB, and with target mRNAs. These findings confirm
and extend a recent report that a GLD2 enzyme is the longsought PAP responsible for cytoplasmic polyadenylation in
oocytes (Barnard et al. 2004). Previous work identified
cytoplasmic PAPs closely related to the nuclear enzyme,
but their biological roles have not been identified unambiguously (Ballantyne et al. 1995; Gebauer and Richter
1995).
XlGLD-2 protein is both cytoplasmic and nuclear
(Fig. 2). The role of the nuclear enzyme is unclear. However, the two GLD2 homologs in S. cerevisiae, TRF4 and
TRF5, both are nuclear proteins (Huh et al. 2003), and
have been strongly implicated in RNA quality control. They
appear to polyadenylate abberant initiator tRNA molecules,
triggering their decay by the nuclear exosome (Kadaba et
al. 2004). Nuclear GLD2 protein in oocytes may have an
analogous role. It is unlikely that the nuclear enzyme is
required for cytoplasmic polyadenylation events after
nuclear breakdown during oocyte maturation, since those
reactions proceed unabated in enucleated oocytes (Fox
et al. 1989).

FIGURE 6. Analysis of mGLD2 and hGLD2 mRNAs. (A) Tissue
distribution of mGLD2 mRNA; 10 mg of total RNA from each of
the indicated tissues was analyzed by Northern blotting, using a probe
directed against the entire ORF region of mGLD2. GAPDH mRNA
served as a loading control. (B) Distribution of hGLD2 mRNAs within
human brain; 2 mg of RNA prepared from each of the indicated
regions of the brain (Ambion) was analyzed by hybridization with a
probe directed against a portion of the hGLD2 ORF. 28S rRNA
stained with ethidium bromide served as a loading control.
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We focused on mammalian GLD2 mRNAs in the brain,
because the clearest instances of regulated cytoplasmic
polyadenylation in the soma occur in the nervous system
(see Introduction). Three lines of evidence suggest that the
mammalian GLD2 plays an important role in synaptic
plasticity. First, human GLD2 protein physically interacts
with Xenopus CPEB and is active in vitro (Figs. 3, 4).
Further, as tethered proteins, mouse and human GLD2
potentiate translation in the oocyte via polyadenylation
and are PAPs in vitro (Fig. 3; Kwak et al. 2004). Second,
the spatial distribution of mGLD2 mRNA in the hippocampus strikingly parallels that of mCPEB1 and Pumilio1
(Fig. 8); in the cerebellum, mGLD2 mRNA colocalizes with
those of other CPEB isoforms (Fig. 9). Proteins related to
Pumilio (PUF proteins) are required for learning in Drosophila
(Dubnau et al. 2003), are found in complexes with CPEB in
Xenopus (Nakahata et al. 2001), and localize to dendrites in
FIGURE 7. The pattern of mGLD2 mRNA abundance in neuronal
cell populations in the mouse brain is similar to those of mCPEB1 and
mPumilio1 mRNAs. (A) In situ hybridization on sagittal mouse brain
sections using an 35S-labeled mGLD2 RNA probe that detects total
mGLD2 mRNA (i.e., mGLD2(L) plus mGLD2(S)). The detected pattern of mGLD2 mRNA is consistent with expression in the major
neuronal cell layers in the olfactory bulb, cerebral cortex, cerebellum,
and hippocampus, each of which is labeled. (A–G) Bar, 4 mm.
(B) Same as A, but using a probe specific to the unique region of
the 30 UTR of mGLD2(L). (C) Same as A, but hybridized to a probe
with the same sense as mGLD2 mRNA. (D–G) Adjacent sections
hybridized with the indicated probes to detect mCPEB1 (D),
mCPEB4 (E); Pumilio1 (F) and Quaking (G) mRNAs.

The presence of XlGLD-2 on mRNAs destined to
receive poly(A), but not yet doing so, implies that the
enzyme is kept inactive in the G complex prior to the
onset of meiotic maturation. Activation could involve
the removal of inhibitory modifications of GLD2; recombinant, presumably unmodified GLD2, purified from bacteria, is active. Alternatively, the G complex may contain
specific repressors of GLD2’s enzyme activity, whose
action is relieved during oocyte maturation. In C. elegans,
protein partners of GLD-2 have been identified that
stimulate its activity and interact with gld-2 genetically
(Wang et al. 2002). Whatever the repression mechanism,
it is striking that XlGLD-2 produced in oocytes and
tethered to an mRNA is active, and so must escape the
inhibition.
The widespread distribution of mammalian GLD2
mRNA suggests that regulated polyadenylation occurs in
many tissues. In cultured somatic cells, repressed mRNAs
are deadenylated and almost certainly can be readenylated
and reactivated (Muckenthaler et al. 1997). Likely examples
of regulated increases in poly(A) length on cellular and
viral mRNAs have been described (for example, Dehlin
et al. 1996). It will be of interest to determine whether
the GLD2 PAP is required for these events.
1124
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FIGURE 8. The distribution of mGLD2 in hippocampus is nearly
identical to those of mCPEB1, mPumilio1, and ARC. Darkfield microscopy of 35S-labeled RNA probes on radiographic emulsion-coated
sections. (A–G) Bar, 200 mm. (A–E) mGLD2 mRNA was detected in
the pyramidal cell layers (CA1 through CA3) of the hippocampus and
granule cell layers (GCL) of the dentate gyrus (A). Nearly identical
distributions were detected in adjacent sections hybridized with
probes complementary to mCPEB1 (B), Pumilio1 (C), or ARC (D).
The mRNA for the RNA binding protein Quaking, which is expressed
primarily in glial cells, was more abundant and distributed differently
than mGLD2 (E). (F, G) Three hours of seizure activity induced by
pentylenetetrazole (PTZ; 50 mg/kg intraperitoneal), increased ARC
expression in dendritic and cellular layers of the dentate gyrus (F).
(The dark area over the granule cell layer is overexposed silver grains).
In contrast, PTZ treatment did not change the abundance or distribution of mGLD2 mRNA (G).
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properties. For example, mCPEB3 mRNA increases dramatically in abundance after drug-induced seizures (Theis et
al. 2003) and resembles the Aplysia neuronal CPEB, which
possesses prion-like properties (Si et al. 2003b). We suggest
that GLD2 is required for regulated polyadenylation and
sustained translation of dendritic mRNAs.

MATERIALS AND METHODS
Cloning Xenopus GLD-2

FIGURE 9. mRNAs encoding CPEB isoforms are differentially
expressed in mouse cerebellum. Darkfield microscopy of 35S-labeled
RNA probes on emulsion-coated sections. (A–E) Bar, 100 mm. (A)
mGLD2 mRNA is found in the major neuronal cell populations in the
cerebellum, including the granule cell layer (GCL) and the Purkinje
cell layer (PCL), with less prominent expression in the cell-sparse
molecular cell layer (MCL). (B) mCPEB1 expression was confined to
Purkinje neurons (arrows). (C) mCPEB2 was expressed in a similar
pattern to mGLD-2. (D) mCPEB3 was expressed in a similar pattern
to mGLD-2 except that more prominent labeling was evident in cells
of the MCL. (E) mCPEB4 was expressed in a similar pattern to
mGLD-2 except that more prominent labeling was present in cells
within the PCL.

mammals (Ye et al. 2004). Third, mCPEB1, whose mRNA
colocalizes with that of mGLD2 in the hippocampus (Fig. 8),
is required for the late phase of long-term potentiation
(Alarcon et al. 2004).
The colocalization in the brain of GLD2 mRNA with
Pumilio and CPEB mRNAs is striking. We suggest that
Pumilio-mediated repression is coordinated with cytoplasmic polyadenylation via GLD2 and CPEB. The proteins
could co-occupy an mRNA, silence its translation until
synaptic stimulation, and then activate it. Alternatively, as
appears to be the case in Xenopus oocytes (Figs. 4, 5), GLD2
and ‘‘repression’’ proteins may reside in distinct complexes
prior to stimulation, perhaps associated with different
mRNA targets. The fact that mCPEB1 colocalizes with
mGLD2 in the hippocampus, while mCPEB2, 3, and 4
colocalize in the cerebellum, implies regional differences
in GLD2/CPEB complexes. Region-specific interactions
of the multiple CPEBs with GLD2 may yield special

Degenerate primers for Xenopus GLD-2 were designed based on
multiple sequence alignment of C. elegans GLD-2 and known
homologs (Wang et al. 2002). The template used for PCR was
DNA from an oligo(dT)-primed, Xenopus oocyte cDNA library
(Romanowski et al. 1996). Seminested PCR was performed using
primers DG1 and DG3, and then DG2 and DG3, at 50 C (for
primer sequences, see Table 1). A single prominent DNA product
was obtained, cloned into pT7Blue (Novagen), and sequenced.
Two clones sequenced in their entirety were identical and showed
extensive similarity to C. elegans and mammalian GLD-2 proteins
(Kwak et al. 2004), but little similarity to conventional PAPs. To
identify the 50 and 30 ends of the cDNA, PCR was performed with
primer pairs that anneal to the 50 end of the cDNA (XGLD-2-5)
and 50 flanking vector (pVP16-1); or to 30 end of the cDNA
(xgld2-10) and to 30 flanking vector sequences (pVP16-2). The
full-length ORF was then amplified by high-fidelity PCR from the
cDNA library, using primers xgld2SmaN and xgld2SmaC, and
inserted into the Sma1 site of pGEX6P1, to generate pLW071.
The cDNA XlGLD-2 sequence was used as a reference sequence
in BLAST to search databases from National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.
gov/BLAST), the National Institute for Basic Biology (NIBB), and
the X. laevis EST project (http://xenopus.nibb.ac.jp). These
searches yielded multiple ESTs that were members of either Contig026310 (11 EST sequences) or Contig029930 (six EST
sequences) from the NIBB database; UniGene cluster Xl.1354
(42 EST sequences) or Xl.15643 (19 EST sequences) from the
NCBI database. ESTs of each group were obtained from NIBB,
purchased for the IMAGE consortium (Open Biosystems), and
fully sequenced. Clones NIBB:XL084p08, NIBB:XL080o08,
IMAGE:5084876, and IMAGE:6638921 are representative of
NIBB Contig026310 and UniGene cluster Xl.1354, which represent our original clone, and whose gene was called XLGLD-2A.
Clones NIBB:XL074e24, IMAGE:5077998, and IMAGE:6643643
are representative of NIBB Contig029930 and UniGene cluster
Xl.15643, whose gene was called XlGLD-2B. XlGLD-2B corresponds to the clone described in Barnard et al. (2004). ESTs
representative short and long 30 UTRs also were identified. These
include XL009c13 and XL058d09 (XlGLD-2(S)), and XL084p08
and IMAGE:35492925 (XlGLD-2(L)). Both XlGLD-2A and
XlGLD-2B encode a 509-amino-acid-long protein.
XlGLD-2A and XlGLD-2B ORFs were tested for sequence similarity to Xenopus tropicalis cDNA and ESTs via BLAST searching
against the Sanger X. tropicalis EST database (www.sanger.ac.uk/
cgi-bin/blast/submitblast/x–tropicalis). Both X. laevis proteins
were related to NCBI Unigene XP–342174.1 (i.e., TEgg044c10,
TEgg130h16, and TEgg037n22).
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TABLE 1. Oligonucleotides
Oligo

Sequence

Use

1
2
3
4
5
6
7
8
9
10

DG1
DG2
DG3
xgld2-10
xgld2-5
pVP16-1
pVP16-2
xgld2SmaN
xgld2SmaC
xD242f

GCIAARGTICCIATHRTIAARTTY
CCIYTIGTIYTNGTIRTIAARAARTGG
RTCRAAIGGITCYTCIAYRCAIAY
TTGACTGGAGCAAAGACATC
TGGCCCACTTTTTAATGACC
CTACGGCGCTCTGGATATGG
CCTCTACAAATGTGGTATGG
CGCCCGGGGATGTACCCTAACTCCCCGAGCC
CGCCCGGGTCATAAAGAGTTCATTTTTTTCACG
GAATCAGTGATGCAGcTTTGTGCCTGGTTTTAAAAGAG

11

xD242r

CTCTTTTAAAACCAGGCACAAAgCTGCATCACTGATTC

12
13
14
15
16

Xlgld-2aNhel
Xlgld-2aXhol
Xlgld-2bNhel
Xlgld-2bXhol
cycB1-74

CCGCTAGCGCTAGCATGTACCCTAACTCCCCCAGCC
CCCCTCGAGCTCGAGTCATAAAGAGTTCATTTTTTTCACG
CCGCTAGCGCTAGCATGTACCCTAACTCCCCCAGCCTGGGCCGC
CCCCTCGAGCTCGAGTCATAACGAGTGCATTTTTTTCATGATTCC
GCAGGTTTGCGCTTGAGAAAATGTCAC

17

cycB1-1010anti GGAGGAAGCAGCTGCTATTTGGGAAGGCG

18

cmos-361

TACAGAGGGGAGACGGTGGCGCTG

19

cmos-3’anti

CCACTTAAACAGCAATGCAACAC

20

Actin-1801

CAACTGGAATAAGGGCAGACTTCC

21

Actin-2227anti

GGGCCTCAGTATCAATTTCCAACC

22

L1-1033

GCTGAACCCATATGCAAAGACCGC

23

L1-3’anti

ACAGAATTTATTGAGTAAATCC

24
25

GLD-2(L) F
GLD-2(L) R

26
27
28
29
30
31
32
33

CPEB-1
CPEB-1
CPEB-2
CPEB-2
CPEB-3
CPEB-3
CPEB-4
CPEB-4

TTATGGCATGACTTTTCAGCA
GGCCAGTGAATTGTAATAGCACTCACTATAGGGAGGCGTCC
GTTTTCTGCTGTTTCCT
CATCTTGGGACCTTCTTGGA
AAGACCCAAGGGATTACC
GGTCGCTCTTCCCTATTTCC
TCCAAAGGCTGAGAACCATC
CCCTTCTCCAGCAATGTGAT
CTCGTTCCCCATTTTGACAT
CCTCACTGCTTCACTCACCA
AACAAAGCGGGCACTGATAG

F
R
F
R
F
R
F
R

degenerate PCR
degenerate PCR
degenerate PCR
Forward primer, XIGLD-2A (1448-1267)
Reverse primer, XIGLD-2A (1170-1189)
XIGLD-2 identification (pVP16 MCS)
XIGLD-2 identification (pVP16 MCS)
Forward primer, XIGLD-2A (178-199)
Reverse primer, XIGLD-2A (1683-1707)
Forward primer, XIGLD-2A active-site
mutagenesis (887-924)
Reverse primer, XIGLD-2A active-site
mutagenesis (887-924)
Forward primer, XIGLD-2A (178-199)
Reverse primer, XIGLD-2A (1683-1707)
Forward primer, XIGLD-2B (139-168)
Reverse primer, XIGLD-2B (1639-1568)
Forward primer, cyclin B1 (accession no.
J03166, 74-100)
Reverse primer, cyclin B1 (accession no.
J03166, 1010-1038)
Forward primer, cmos (accession no.
X13311, 361-384)
Reverse primer, cmos (accession no.
X13311, 3073-3095)
Forward primer, actin (accession no.
M24769, 1801-1824)
Reverse primer, actin (accession no.
M24769, 2227-2251)
Forward primer, L1 (accession no.
BC054956, 1033-1056)
Reverse primer, L1 (accession no.
BC054956, 1279-1300)
Forward primer, mGLD-2(L) (1907-1928)
Reverse primer, mGLD-2(L) probe
(2484-2504)
Forward primer, CPEB1 (808-828)
Reverse primer, CPEB1 (1246-1266)
Forward primer, CPEB2 (773-793)
Reverse primer, CPEB2 (1198-1218)
Forward primer, CPEB3 (958-978)
Reverse primer, CPEB3 (1412-1432)
Forward primer, CPEB4 (97-117)
Reverse primer, CPEB4 (643-663)

Numbering of sequences (last column) are based on the following: oligonucleotides 4, 5, and 8–13, GenBank accession BC082438 (IMAGE:
50848776); oligonucleotides 14 and 15, GenBank accession BC076832 (IMAGE:6643643); oligonucleotides 16–23, indicated GenBank
accession numbers; and oligonucleotides 24–33, sequences in the Unigene database.

Cloning mGLD2 and hGLD2
Clones corresponding to full-length mGLD2 and hGLD2 proteins
have been described (Kwak et al. 2004). hGLD2D8 and hGLD2D11
cDNAs were obtained by reverse transcription and PCR from total
RNA, using hGLD2 gene-specific primers. mRNA and EST sequences
representative of mGLD2 are represented in UniGene cluster
Mm.242865, with polyadenylated representatives for mGLD2(S)
(IMAGE:3595512 and NM–133905), and for mGLD2(L)
(BB787817). mRNA and EST sequences representative of hGLD2
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are represented in UniGene cluster Hs.418198, with polyadenylated
representatives for hGLD2(S) (GenBank entry NM–173797), and for
hGLD2(L) (IMAGE:4824607 and GenBank entry BC047581.1).

DNA constructs
pLW071
To express GST-XlGLD-2A in bacteria, the entire XlLD-2A ORF
was inserted into SmaI-digested pGEX6P-1.
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pLW071(D242A)
To generate the active site mutant of GST-XlGLD-2A, site-directed mutagenesis was performed on pLW071 and primers xD242f
and xD242r.
pLW073
To express MS2/XlGLD-2A in Xenopus oocytes, the XlGLD-2A
ORF was amplified with Xlgld-2aNheI and Xlgld-2aXhoI, and
inserted into the NheI and XhoI sites of p3HA-MSP-CeGLD-2
(Kwak et al. 2004). This replaces CeGLD-2 with XlGLD-2A.
Transcripts were produced by using a T7 promoter.
pLR073
To express MS2-XlGLD-2B in Xenopus oocytes, the XlGLD-2B
ORF was amplified with Xlgld-2bNheI and Xlgld-2bXhoI primers,
and inserted into the NheI and XhoI sites of p3HA-MSP-CeGLD2
(Kwak et al. 2004). This replaces CeGLD-2 with XlGLD-2B. The
mRNA was transcribed from a T7 promoter.
pLW078
To generate the active site mutant of MS2-XlGLD-2A, site-directed mutagenesis was performed on pLW073 and primers xD242f
and xD242r.
pCS2+/HA/XLGLD-2A
To express HA-XlGLD-2A in Xenopus oocytes, the XlGLD-2A
ORF preceded by two HA epitope tag sequences, was inserted
into EcoRI digested pCS2+, and can be transcribed from a SP6
promoter.
pCS2+/MS2/hGLD2
To express MS2-hGLD2 in Xenopus oocytes, a PCR fragment from
p3HA-hGLD2 (Kwak et al. 2004), which contained MS2/hGLD2
ORF, was inserted into BamH1 and Xho1 sites of pCS2+ and can
be transcribed from SP6 promoter.
pCSMS2-hGLD2
To detect the expression of MS2-hGLD2 protein in Xenopus
oocytes, triple HA tags were inserted into pCS2+/MS2/hGLD2 at
the BamH1 site.
pCSMS2-hGLD2D8 and pCSMS2-hGLD2D11
To express and detect alternative splicing variants of hGLD2 in
Xenopus oocytes, hGLD2 ORF in pCSMS2-hGLD2 was replaced
with spliced variants hGLD2D8 and hGLD2D11 ORFs, using
Nhe1 and Xho1, and can be transcribed from a SP6 promoter.
Constructs for tethered assay reporters are pLG-MS2, pLGMS2LucHS, and pJK350, which have been previously described (Kwak
et al. 2004).

pLW073, pLR073, and pLW078 were linearized with EcoR1 and
transcribed with Megascript T7 transcription kit (Ambion).

Oocyte manipulations, injections, and tethered assays
Oocyte injection and progesterone treatment were performed as
described previously (Ballantyne et al. 1997), as were tethered function assays (Kwak et al. 2004). mRNAs were injected at 0.7 mg/mlL.
Enucleations were performed under mineral oil (Lund and Paine
1990; Dickson et al. 2001).

Northern blotting
One microgram of total RNA (unless otherwise stated) was electrophoresed in individual lanes on a 1.2% agarose/formaldehye/
13 MOPS gel. The gel was transferred to GeneScreen plus (Perkin
Elmer Life Sciences, Inc.) using Stratagene’s PosiBlotter (Stratagene, Inc.). 32P-labeled cDNA (2 3 106 c.p.m./mL) was hybridized
to the membrane in Hybrisol I (Intergen, Inc.). Northern blots
were washed and exposed to a phosphorimager screen for 1 d.
Screens were scanned on a Storm phosphorimager (Molecular
Dynamics Inc.).
XLGLd-2
Northern blotting was performed using 25 mg of total RNA, 25 mg
of nonpolyadenylated RNA, and 800 ng of oligo(dT)-purified
oocyte RNA. The 32P-dCTP–labeled DNA probe comprised the
entire XlGLD-2A ORF.
mGLD2
Northern blotting was performed by using 20mg of total RNA or
oligo(dT)-purified RNA from NIH-3T3 cells, 10mg of total RNA
from various mouse tissues, and on 1 mg of total RNA from
mouse brain, cerebellum, P1, and synaptosomal preps.
hGLD2
Northern blotting was performed by using 2mg of total RNA from
various human tissues (Ambion), and a 32P-UTP–labeled probe
anti-sense to the entire hGLD2 ORF.

In vitro PAP assay
One hundred nanograms of purified recombinant GST-XlGLD-2A,
GST/XlGLD-2A(D242A), or GST/hGLD2 proteins, were incubated
with 32P-end–labeled L1 RNA substrate (sequence UUAUCUCAU
GUUCAGCACUUUGGAUUUACUCAAUAAAUUCUGUU (Integrated DNA Technologies), 20 U RNAsin (Promega), and 1 mM
rNTPs, in PAP buffer (25 mM Tris-HCl at pH 7.0, 40 mM KCl, 0.5
mM MnCl2, 0.05 mM EDTA, 0.5 mM DTT, and 0.2 mg/mL BSA;
USB). Reactions were stopped by with 23 RNA loading dye
(Ambion).

a-XGLDLD-2A antibodies
In vitro transcription
pCS2+ based constructs were linearized with Not1 and transcribed with Megascript SP6 transcription kit (Ambion).

Recombinant GST-XlGLD-2A was purified as described for GSTFBF-1 in Bernstein et al. (2005). Purified protein was injected into
guinea pigs (Cocalico Biologicals). Antibody specificity was tested
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by using the TnT T7-Quick couple transcription/translation system (Promega). This antibody is referred to in the text as
aXlGLD-2.

extraction with TRI reagent (Sigma) and solubilized in 20 mL of
DEPC water.
Where indicated, oocytes were injected with mRNAs coding for
tagged forms of GLD2 and incubated at room temperature for
6 h, prior to preparation of extracts.

Interactions with GST fusion proteins
All steps were performed at 4 C; 4mg of GST-XlGLD-2A, GST-PUF8, or GST was bound to glutathione-Sepharose 4B (Amersham
Pharmacia Biotech) and equilibrated with MSB. Twenty stage
VI oocytes were homogenized in 200mL MSB and centrifuged at
3000 rpm in a Eppendorf 5415C microcentrifuge for 10 min.
The soluble fraction was incubated overnight with recombinant
protein bound to 20mL of glutathione beads. Samples were then
centrifuged at 3000 rpm for 5 min and washed thrice with 500mL of
MSB, and the fraction associated with glutathione beads was eluted
by boiling in 50mL of SDS-PAGE loading dye for 5 min.

RT-PCR

Westerns

In situ hybridizations

The presence of XlGLD-2 protein in stage VI oocytes, eggs, and
different stages of embryogenesis was monitored by lysing groups
of 10 oocytes, eggs, or embryos in 100mL of MSB; centrifuging
3000 rpm in a eppendorf 5415C microcentrifuge for 10 min at
4 C; and mixing the soluble fraction with 2 3 SDS loading dye.
Westerns were done for protein representative of one oocyte/egg/
embryo. aXlGLD-2 antibody was used at 1:1000 dilution in
blotto. HRP-conjugated anti-Guinea pig secondary antibody
(Sigma) was used at a 1:10,000 dilution. Western blotting with
other antibodies were done following the providers’ protocol.

Sections on slides were fixed in 4% paraformaldehyde in PBS for 2 h
at 4 C. Slides were then washed for 5 min in 23 SSC three times,
and incubated in 0.2 mg/mL Proteinase K (Qiagen) in 0.1 M
Tris base and 50 mM EDTA (pH 8.1) for 10 min at 37 C. Slides
were washed in 23 SSC at room temperature for 2 min and
incubated in 0.1 M TEA at room temperature with rapid stirring,
and acetic anhydride was added to a final concentration of 0.25% (v/
v) with rapid stirring for 10 min. Slides were then washed in 23 SSC
for 5 min. Finally, sections were dehydrated in an ascending ethanol
series and air-dried for 15 min.
Templates for generating 35S-labeled RNA probes were generated by
PCR of a mouse brain cDNA library using T7 anchored primer pairs
(Table 1). In vitro transcription was carried out in 13 Transcription
Optimized Buffer, 10 mM DTT; 1 U/mL RNasin; 0.375 mM ATP, CTP,
and GTP; 1 U/mL T7 RNA polymerase (all Promega); 3.5 mCi/mL
[a-35S]UTP (PerkinElmer); and 100 ng template DNA and incubated
for 2 h at 37 C. RQ1 RNase free DNase (Promega) was added at a
concentration of 0.15 U/mL and incubated for an additional 15 min at
37 C. The labeled probes were purified using ProbeQuant G-50 Micro
columns (Amersham Biosciences). Probes were diluted in hybridization solution (33 SSC, 10% dextran sulfate, 13 Denhardt’s solution,
0.2 mg/mL tRNA, 50 mM NaPO4 buffer, and freshly added DTT to
50 mM final concentration) to 106 cpm/100 mL). One hundred
microliters of the hybridization solution at 55 C with labeled probe
was applied to each slide. Slides were then covered with coverlips and
incubated at 55 C in a hybridization chamber saturated with 75%
formamide for 16 h.
After hybridization, coverslips were removed and slides were
washed three times in 23 SSC with 2 mM DTT at room temperature for 10 min. Slides were incubated in 1.5 U/mL RNase A
(Qiagen) in RNase buffer (10 mM Tris-HCl and 0.5 M NaCl at
pH 8.0) at 37 C for 1 h followed by washes in 13 SSC with 1 mM
DTT at room temperature for 5 min, 0.53 SSC with 1 mM DTT
at room temperature for 5 min, and 0.13 SSC with 2 mM DTT at
70 C for 1 h. The sections were then dehydrated in an ascending
series of ethanol and then were air-dried. Sections were exposed to
a phosphorimager screen and were subsequently scanned on a
Storm phosphorimager. Slides were then covered with NTB2
emulsion (Eastman Kodak Co.) and exposed for 28 d for analysis
of silver grain distribution. After development, slides were

Immunoprecipitations
For immunoprecipitations, antibodies were purified and bound
on Protein A–Sepharose (Sigma). 15mL of serum was incubated
with 25mL of Protein A–Sepharose following in 150 mL of PBS, for
4 h at 4 C. Sepharose was then centrifuged at 3000 rpm and
washed three times with PBS.
Antibodies directed against the following proteins have been
described previously and were gifts of the indicated laboratories:
a-CPEB (Dickson et al. 2001), aCPSF100 (Jenny et al. 1994);
a-CPSF73 (gift of Dr. D.L. Bentley, University of Colorado
HSC), aXenopus Pumilio (Nakahata et al. 2003), a-XlPABP2
(Good et al. 2004), and a-maskin (gift of Dr. C. Wiese).
Protein A–Sepharose bound antibodies were equilibrated with
MSB (150 mM NaCl, 0.1% NP-40, 50 mM Tris-Cl at pH 8) and a
protease inhibitor cocktail (Boehringer Manneheim) (Dickson
et al. 2001) and incubated overnight at 4 C with oocyte extract
(0.1 oocyte/mL). Samples were centrifuged at 3000 rpm in a
Eppendorf 5415C microcentrifuge for 5 min and washed three
times with 500mL modified MSB, and the bound fraction was
eluted by boiling in 50mL of SDS loading dye for 5 min.
For RNA coimmunoprecipitations and RNA dependence analysis of the CPEB-XlGLD2 interaction, modified MSB was made
with DEPC-treated water, 1 mM DTT, and 1 U/mL rRNAsin, with
or without 1 mL RNAseA/T1 mix (Ambion) per 10 mL of lysate.
The Protein A–Sepharose bound antibodies were incubated with
oocyte lysate (0.04 oocytes/mL) 5 h at 4 C and washed three times
with 200mL of DEPC-based MSB. RNA was eluted from beads by
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Reverse transcriptase reactions were performed using one third of
the total coimmunoprecipitated sample or 1 mg of total oocyte
RNA. Oligo(dT)-primed reverse transcription reactions were performed by using the GeneRacer Superscript II reverse transcription module (Invitrogen), as described by manufacturer. Three
microliters of the Reverse transcription reaction was used for PCR
with gene-specific primers for 35 cycles with annealing temperatures of 55 C (c-mos and actin), 65 C (cyclinB1), and 45 C (L1).
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counterstained with Nissl stain and dehydrated through a graded
series of ethanol and xylene. A coverslip was then applied. Images
were taken with a Leica DC 300F digital camera linked to Image
Pro-Plus software on a PC through a Leica DMRX microscope.
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